Literature DB >> 16084091

Phosphorylation and activation of STAT proteins by hypoxia in breast cancer cells.

Moon Young Lee1, Youn Hee Joung, Eun Joung Lim, Jong-Hwan Park, Sang-Kyu Ye, Taekyu Park, Zheng Zhang, Dong Ki Park, Kwang Jeon Lee, Young Mok Yang.   

Abstract

Several constitutively activated signal transducers and activators of transcription (STAT) proteins have been observed in a wide number of human cancer cell lines and primary tumors. Normal cells maintain normoxic conditions but tumor cells are characteristically hypoxic. We studied the altered activation and tyrosine phosphorylation of STATs under hypoxic conditions (2% O2) or desferrioxamine (DFO) treatment in mouse mammary epithelial cells (HC11) and a human breast cancer cell line (MCF-7). STAT1, -3 and -5 proteins are especially important and are observed at elevated levels in tumorigenesis. We also investigated the serine phosphorylation of STAT1, -3, and -5 under hypoxic conditions or DFO treatment in HC11 and MCF-7 cells. Here we show that DFO or hypoxia stimulates the tyrosine and/or serine phosphorylation and the expression of STAT proteins in breast cancer cells. Our data suggest that DFO or hypoxic condition is a critical stimulator for the activation of STAT proteins in breast cancer cells. These results may provide the basis for identifying another mechanism of breast tumorigenesis via the JAK/STAT pathway in hypoxia. Also, activation of STAT proteins by hypoxia may play an important role in the physiological phenomenon of embryonic stem cells and old cells with hypoxic conditions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16084091     DOI: 10.1016/j.breast.2005.05.005

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  17 in total

1.  Proteomic characterization of novel alternative splice variant proteins in human epidermal growth factor receptor 2/neu-induced breast cancers.

Authors:  Rajasree Menon; Gilbert S Omenn
Journal:  Cancer Res       Date:  2010-04-13       Impact factor: 12.701

2.  Hypoxia Moderates γ(1)34.5-Deleted Herpes Simplex Virus Oncolytic Activity in Human Glioma Xenoline Primary Cultures.

Authors:  Gregory K Friedman; Marilyn C Haas; Virginia M Kelly; James M Markert; George Yancey Gillespie; Kevin A Cassady
Journal:  Transl Oncol       Date:  2012-06-01       Impact factor: 4.243

3.  EGFRvIII-Stat5 Signaling Enhances Glioblastoma Cell Migration and Survival.

Authors:  Alison Roos; Harshil D Dhruv; Sen Peng; Landon J Inge; Serdar Tuncali; Michael Pineda; Nghia Millard; Zachary Mayo; Jennifer M Eschbacher; Joseph C Loftus; Jeffrey A Winkles; Nhan L Tran
Journal:  Mol Cancer Res       Date:  2018-05-03       Impact factor: 5.852

4.  Hypoxia induces chemoresistance in ovarian cancer cells by activation of signal transducer and activator of transcription 3.

Authors:  Karuppaiyah Selvendiran; Anna Bratasz; M Lakshmi Kuppusamy; Mia F Tazi; Brian K Rivera; Periannan Kuppusamy
Journal:  Int J Cancer       Date:  2009-11-01       Impact factor: 7.396

Review 5.  Enhanceosomes as integrators of hypoxia inducible factor (HIF) and other transcription factors in the hypoxic transcriptional response.

Authors:  Matthew R Pawlus; Cheng-Jun Hu
Journal:  Cell Signal       Date:  2013-05-21       Impact factor: 4.315

6.  Hypoxia modulates A431 cellular pathways association to tumor radioresistance and enhanced migration revealed by comprehensive proteomic and functional studies.

Authors:  Yan Ren; Piliang Hao; Bamaprasad Dutta; Esther Sok Hwee Cheow; Kae Hwan Sim; Chee Sian Gan; Sai Kiang Lim; Siu Kwan Sze
Journal:  Mol Cell Proteomics       Date:  2012-11-30       Impact factor: 5.911

7.  STAT3 and HIF1α cooperatively activate HIF1 target genes in MDA-MB-231 and RCC4 cells.

Authors:  M R Pawlus; L Wang; C-J Hu
Journal:  Oncogene       Date:  2013-04-22       Impact factor: 9.867

Review 8.  Signal transducer and activator of transcription 5A/B in prostate and breast cancers.

Authors:  Shyh-Han Tan; Marja T Nevalainen
Journal:  Endocr Relat Cancer       Date:  2008-06       Impact factor: 5.678

9.  Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target.

Authors:  Uksha Saini; Shan Naidu; Adam C ElNaggar; Hemant Kumar Bid; John J Wallbillich; Kristin Bixel; Chelsea Bolyard; Adrian A Suarez; Balveen Kaur; Periannan Kuppusamy; John Hays; Paul J Goodfellow; David E Cohn; Karuppaiyah Selvendiran
Journal:  Oncogene       Date:  2016-06-13       Impact factor: 9.867

10.  The HIF target MAFF promotes tumor invasion and metastasis through IL11 and STAT3 signaling.

Authors:  Eui Jung Moon; Stephano S Mello; Caiyun G Li; Jen-Tsan Chi; Kaushik Thakkar; Jacob G Kirkland; Edward L Lagory; Ik Jae Lee; Anh N Diep; Yu Miao; Marjan Rafat; Marta Vilalta; Laura Castellini; Adam J Krieg; Edward E Graves; Laura D Attardi; Amato J Giaccia
Journal:  Nat Commun       Date:  2021-07-14       Impact factor: 17.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.